DENVER, CO May 3, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our...
DENVER, CO April 18, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for unsedated Transnasal Endoscopy (TNE), is pleased to announce that Children’s Hospital Los...
DENVER, CO, April 13, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), announced that the company received an investment...
Jonathan T. Hartmann appointed as President and Chief Executive Officer Ryan Hartman appointed as Chief Operating Officer DENVER, CO, April 6, 2023 – EvoEndo®, Inc. (“EvoEndo” or the “Company”), a...
Patients with conditions like Eosinophilic Esophagitis (EoE) are required to undergo routine endoscopies every 1-2 months, usually necessitating them to go under anesthesia. Unsedated options, like...
Maia Belay of FOX 8 News Cleveland recently met with one of University Hospitals Rainbow Babies & Children’s Hospital patients, Nick Demers, and the Chief of Pediatric Gastroenterology & Nutrition,...
DENVER, CO, EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the Centers for...
BOSTON, October 24, 2022–MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced...
DENVER, CO—EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has been selected to exhibit the EvoEndo® Single-Use Endoscopy System at...
Completes $8.4M Series A Financing to Initiate Rollout of the EvoEndo® Model LE Single-Use Gastroscope Gastroenterologists can now offer pediatric and adult patients a safer, faster, and more...
